Clinical Trial Update: A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of combining Panzem NCD with Avastin in metastatic carcinoid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor

Drugs mentioned

• Avastin (bevacizumab)
• Panzem NCD

Snippet

Sponsor: CASI Pharmaceuticals, Inc. | Conditions: Carcinoid Tumor | Phase 2 | Status: COMPLETED